Predictors of insulin resistance in patients with obesity: A pilot study

Angiology

Volumn 65, Issue 1, 2014, Pages 22-30

  Stȩpień, Mariusz ^a   Stȩpień, Anna ^a   Wlazeł, Rafał N ^a   Paradowski, Marek ^a   Rizzo, Manfredi ^b,c   Banach, Maciej ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF PALERMO   (Italy)

^c Euro Mediterranean Institute of Science and Technology   (Italy)

Author keywords

cytokines; inflammatory markers; insulin resistance; obesity; obesity indices

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; BODY HEIGHT; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; OBESITY; PILOT STUDY; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGED; BLOOD; BODY MASS; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADIPONECTIN; ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MALE; MIDDLE AGED; OBESITY; PILOT PROJECTS; RESISTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84888604123     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319712468291     Document Type: Article

References (36)

1. Klöting N, Fasshauer M, Dietrich A, et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab. 2010 ; 299 (3). E506 - E515
2. Rabe K, Lehrke M, Parhofer KG, Broedl UC. Adipokines and insulin resistance. Mol Med. 2008 ; 14 (11-12). 741-751
3. Luis DA de, Sagrado MG, Conde R, et al. Relation of resistin levels with cardiovascular risk factors and insulin resistance in non-diabetes obese patients. Diab Res Clin Pract. 2009 ; 84 (2). 174-178
4. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010 ; 316 (2). 129-139
5. Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation and insulin resistance. Eur Cytokine Netw. 2006 ; 17 (1). 4-12
6. Athyros VG, Tziomalos K, Karagiannis A, Anagnostis P, Mikhailidis DP. Should adipokines be considered in the choice of the treatment of obesity-related health problems?. Curr Drug Targets. 2010 ; 11 (1). 122-135
7. Katsiki N, Mikhailidis DP, Gotzamani-Psarrakou A, Yovos JG, Karamitsos D. Effect of various treatments on leptin, adiponectin, ghrelin and neuropeptide Y in patients with type 2 diabetes mellitus. Expert Opin Ther Targets. 2011 ; 15 (4). 401-420
8. Karayannis G, Giamouzis G, Tziolas N, et al. Association between epicardial fat thickness and weight homeostasis hormones in patients with noncachectic heart failure [published online May 30, 2012]. Angiology. :
9. Gluba A., Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M.. Metabolic syndrome and renal disease [published online February 02, 2012]. Int J Cardiol. :
10. Barylski M, Małyszko J, Rysz J, Myliwiec M, Banach M. Lipids, blood pressure, kidney - what was new in 2011?. Arch Med Sci. 2011 ; 7 (6). 1055-1066
11. Olszanecka-Glinianowicz M, Kocełak P, Nylec M, Chudek J, Zahorska-Markiewicz B. Circulating visfatin level and visfatin/insulin ratio in obese women with metabolic syndrome. Arch Med Sci. 2012 ; 8 (2). 214-218
12. Gordon L, Ragoobirsingh D, Morrison E, McGrowder D, Choo-Kang E, Martorell E. Dyslipidaemia in hypertensive obese type 2 diabetic patients in Jamaica. Arch Med Sci. 2010 ; 6 (5). 701-708
13. Katsiki N, Mikhailidis DP, Gotzamani-Psarrakou A, Didangelos TP, Yovos JG, Karamitsos DT. Effects of improving glycemic control with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study. Open Cardiovasc Med J. 2011 ; 5: 136-147
14. Karakas P, Bozkir MG. Anthropometric indices in relation to overweight and obesity among Turkish medical students. Arch Med Sci. 2012 ; 8 (2). 209-213
15. Lee CMY, Huxley RR, Wildman RP, Woodward M. Indices of abdominal obesity are better discriminators of cardiovascular risk factor than BMI: a meta-analysis. J Clin Epidemiol. 2008 ; 61 (7). 646-653
16. Bergman RN, Stefanovski D, Buchanan TA, et al. A better index of body adiposity. Obesity (Silver Spring). 2011 ; 19 (5). 1083-1089
17. Amato MC, Giordano C, Galia M, et al. Visceral adiposity index. a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010 ; 33 (4). 920-922
18. Ashwell M, Gibson S. Waist to height ratio is a simple and effective obesity screening tool for cardiovascular risk factors: analysis of data from the British National Diet and Nutrition Survey of adults aged 19-64 years. Obesity Facts Eur J Obes. 2009 ; 2 (1). 97-103
19. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J Clin Endocrinol Metab. 2003 ; 88 (10). 4848-4856
20. Stȩpień M, Roniak-Ba̧k K, Paradowski M, et al. Waist circumference, ghrelin and selected adipose tissue-derived adipokines as predictors of insulin resistance in obese patients. Med Sci Monit. 2011 ; 17 (11). 13-18
21. Mahadik SR, Deo SS, Mehtalia SD. Role of adipocytokines in insulin resistance: studies from Urban Western Indian population. Int J Diabetes Metab. 2010 ; 18 (1). 35-42
22. Cnop M, Havel PJ, Utzschneider KM, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of ages and sex. Diabetologia. 2003 ; 46 (4). 459-469
23. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev. 2010 ; 11 (1). 11-18
24. Bozorgmanesh M, Hadaegh F, Azizi F. Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis. 2011 ; 10: 88
25. Stȩpień A, Stȩpień M, Wlazeł R, Paradowski M, Rysz J.. New indices of visceral adiposity and its correlation with hs-CRP in patients with obesity. Clin Exp Med Lett. 2011 ; 52 (3-4). 91-95
26. Melmer A, Lamina C, Tschoner A, et al. Body adiposity index and other indexes of body composition in the SAPHIR study: association with cardiovascular risk factors [published online June 22, 2012]. Obesity (Silver Spring). :
27. Silva M, Vale B, Lemos C, Torres M, Bregman R.. Body adiposity index assess body fat with accuracy in nondialysed chronic kidney disease patients [published online June 22, 2012]. Obesity (Silver Spring). :
28. Schulze MB, Thorand B, Fritsche A, et al. Body adiposity index, body fat content and incidence of type 2 diabetes. Diabetologia. 2012 ; 55 (6). 1660-1667
29. Arbel J, Birati E, Shapira I. Comparison of different anthropometric measurements and inflammatory biomarkers. Int J Inflamm. 2012 ;:
30. Silha JV, Krsek M, Skrha JV, Sucharda P, Nyomba BL, Murphy LJ. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol. 2003 ; 149 (4). 331-335
31. Stȩpień M, Wlazeł RN, Paradowski M, et al. Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients - pilot study. Arch Med Sci. 2012 ; 8 (3). 431-436
32. Ruige JB, Dekker JM, Blum WF, et al. Leptin and variables of body adiposity, energy balance and insulin resistance in a population based study. The Hoorn Study. Diabetes Care. 1999 ; 22 (7). 1097-1104
33. Nishizawa H, Shimomura I, Kishida K, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes. 2002 ; 51 (9). 2734-2741
34. Ferrannini E, Sironi AM, Iozzo P, Gastaldelli A. Intra-abdominal adiposity, abdominal obesity, and cardiometabolic risk. Eur Heart J Suppl. 2008 ; 10 (suppl B). B4 - B10
35. Barylski M, Kowalczyk E, Banach M, Ciecwierz J, Pawlicki L, Kowalski J. Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndrome. Angiology. 2009 ; 60 (1). 87-92
36. Lichnovská R, Gwozdziewiczová S, Hrebícek J. Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects. Cardiovasc Diabetol. 2002 ; 1: 4